Condition: Intracranial Aneurysm · Sponsor: Medtronic Neurovascular Clinical Affairs
The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
This description comes directly from the study's public registry record.
Medtronic Neurovascular Clinical Affairs · 949-837-3700 · rs.nvclinicalartisse@medtronic.com
Always discuss trial participation with your own doctor first.
| Swedish Medical Center | Englewood, Colorado, United States | Recruiting |
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Baptist Medical Center Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Tampa General Hospital | Tampa, Florida, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Advocate Lutheran General Hospital | Park Ridge, Illinois, United States | Suspended |
| Ascension Saint Vincent Hospital - Indianapolis | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Cooper University Health | Camden, New Jersey, United States | Recruiting |
| Albany Medical Center | Albany, New York, United States | Recruiting |
| Buffalo General Medical Center | Buffalo, New York, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02998229